Document
IPR2022-00853, No. 2031 Exhibit - Steven A Rosenberg et al, Use of Tumor Infiltrating Lymphocytes and Interleukin 2 in the Immunotherapy of Patients with Metastatic Melanoma, 319 NEW ENG...
Cite Document
IPR2022-00853, No. 2031 Exhibit - Steven A Rosenberg et al, Use of Tumor Infiltrating Lymphocytes and Interleukin 2 in the Immunotherapy of Patients with Metastatic Melanoma, 319 NEW ENG J MED 1676 19
+ More Snippets
Document
IPR2022-00853, No. 2007 Exhibit - FOOD AND DRUG ADMIN, FDA APPROVAL BRINGS FIRST GENE THERAPY TO THE UNITED STATES Aug 30, 2017, httpswwwfdagovnews eventspress ann...
Cite Document
IPR2022-00853, No. 2007 Exhibit - FOOD AND DRUG ADMIN, FDA APPROVAL BRINGS FIRST GENE THERAPY TO THE UNITED STATES Aug 30, 2017, httpswwwfdagovnews eventspress announcementsfda approval brings first g
+ More Snippets
Document
IPR2022-00853, No. 2021 Exhibit - Carl June Named One of Time���s 100 Most Influential People in the World, PENN MEDICINE Apr 26, 2018, httpspathologymedupennedunewscarl june named...
Cite Document
IPR2022-00853, No. 2021 Exhibit - Carl June Named One of Time���s 100 Most Influential People in the World, PENN MEDICINE Apr 26, 2018, httpspathologymedupennedunewscarl june named one times 100 most
+ More Snippets
Document
IPR2022-00853, No. 2043 Exhibit - Cancer treatment myths Any truth to these common beliefs, MAYO CLINIC March 22, 2022, httpswwwmayoclinicorgdiseases conditionscancerin depthcancera...
Cite Document
IPR2022-00853, No. 2043 Exhibit - Cancer treatment myths Any truth to these common beliefs, MAYO CLINIC March 22, 2022, httpswwwmayoclinicorgdiseases conditionscancerin depthcancerart 20046762 (P.T.A.
+ More Snippets
Document
IPR2022-00853, No. 2027 Exhibit - Supplemental Information Disclosure Statement Initialed by Examiner June 17, 2016, US Patent Application No 14,996,953 (P.T.A.B. Jul. 19, 2022)
Cite Document
IPR2022-00853, No. 2027 Exhibit - Supplemental Information Disclosure Statement Initialed by Examiner June 17, 2016, US Patent Application No 14,996,953 (P.T.A.B. Jul. 19, 2022)
+ More Snippets
Document
IPR2022-00853, No. 1052 Exhibit - Arnold Declaration (P.T.A.B. Apr. 19, 2022)
Cite Document
IPR2022-00853, No. 1052 Exhibit - Arnold Declaration (P.T.A.B. Apr. 19, 2022)
+ More Snippets
Document
IPR2022-00853, No. 1038 Exhibit - Clinical Trial NCT01029366 webpage (P.T.A.B. Apr. 12, 2022)
Cite Document
IPR2022-00853, No. 1038 Exhibit - Clinical Trial NCT01029366 webpage (P.T.A.B. Apr. 12, 2022)
+ More Snippets
Document
IPR2022-00853, No. 1002 Exhibit - Junghans Decl (P.T.A.B. Apr. 12, 2022)
Cite Document
IPR2022-00853, No. 1002 Exhibit - Junghans Decl (P.T.A.B. Apr. 12, 2022)
+ More Snippets
Document
IPR2022-00853, No. 1046 Exhibit - Brentjens (P.T.A.B. Apr. 12, 2022)
Cite Document
IPR2022-00853, No. 1046 Exhibit - Brentjens (P.T.A.B. Apr. 12, 2022)
+ More Snippets
Document
IPR2022-00853, No. 1047 Exhibit - Davila (P.T.A.B. Apr. 12, 2022)
Cite Document
IPR2022-00853, No. 1047 Exhibit - Davila (P.T.A.B. Apr. 12, 2022)
+ More Snippets
Document
IPR2022-00853, No. 1035 Exhibit - McDowell (P.T.A.B. Apr. 12, 2022)
Cite Document
IPR2022-00853, No. 1035 Exhibit - McDowell (P.T.A.B. Apr. 12, 2022)
+ More Snippets
Document
IPR2022-00853, No. 1018 Exhibit - PCTUS2011064191 File History Excerpts (P.T.A.B. Apr. 12, 2022)
Cite Document
IPR2022-00853, No. 1018 Exhibit - PCTUS2011064191 File History Excerpts (P.T.A.B. Apr. 12, 2022)
+ More Snippets
Document
IPR2022-00853, No. 1019 Exhibit - US Provisional Application 61502,649 File History (P.T.A.B. Apr. 12, 2022)
Cite Document
IPR2022-00853, No. 1019 Exhibit - US Provisional Application 61502,649 File History (P.T.A.B. Apr. 12, 2022)
+ More Snippets
Document
IPR2022-00853, No. 1025 Exhibit - Turco (P.T.A.B. Apr. 12, 2022)
Cite Document
IPR2022-00853, No. 1025 Exhibit - Turco (P.T.A.B. Apr. 12, 2022)
+ More Snippets
Document
IPR2022-00853, No. 1032 Exhibit - Klebanoff (P.T.A.B. Apr. 12, 2022)
Cite Document
IPR2022-00853, No. 1032 Exhibit - Klebanoff (P.T.A.B. Apr. 12, 2022)
+ More Snippets